Author:
Bathina A.,Hakanen J.,Doka A.,Raasmaja A.,Pohjanvirta R.
Reference4 articles.
1. WHO (2018) WHO: Obesity and overweight, in Factsheet (WHO)
2. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection;Abraham;Archives of toxicology,1988
3. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure;Xu;International journal of obesity,2015
4. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFbeta, and IDO1;Moyer;Toxicology and applied pharmacology,2016